HRT Financial’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,276
Closed -$37K – 5163
2026
Q2
$37K Buy
+3,276
New +$62.9K ﹤0.01% 3835
2025
Q2
– Sell
-42
Closed -$11K – 2972
2025
Q1
$11K Buy
42
+26
+163% +$14.4K ﹤0.01% 2344
2024
Q4
$14K Buy
16
+2
+14% +$2.62K ﹤0.01% 2253
2024
Q3
$5K Buy
+14
New +$17.3K ﹤0.01% 2268
2021
Q4
– Sell
-2
Closed -$183K – 3515
2021
Q3
$183K Hold
2
– – ﹤0.01% 2724
2021
Q2
$278K Buy
+2
New +$328K ﹤0.01% 2197

Other funds holding GNPX

HRT Financial's GNPX Position: Q3 2026 in Review

HRT Financial sold out of Genprex (GNPX) in Q3 2026, closing a stake of 3,276 shares — an estimated $37K sold.

HRT Financial first reported a position in GNPX in Q2 2021 and held it in 6 quarters. The position peaked at $278K in Q2 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q3 2026.

  • HRT Financial reported no remaining Genprex position as of Q3 2026 after selling out during the quarter.
  • HRT Financial sold 3,276 Genprex shares in Q3 2026, an estimated $37K.
  • HRT Financial first reported a position in Genprex in Q2 2021 and held it in 6 quarters.
  • HRT Financial's Genprex position peaked at $278K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Genprex as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.